← FDA Drug Approvals (Drugs@FDA)

ANDA220866

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LIMITED · Approved 2026-06-01

Drug application

FDA Application #

ANDA220866

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

HETERO LABS LIMITED

First approval

2026-06-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown